Ozempic and similar drugs may lower risks for opioid and alcohol use disorders

A new study published in the scientific journal Addiction has found that people with opioid or alcohol use disorder (OUD, AUD) who take Ozempic or similar medications to treat diabetic/weight-related conditions appear to have a 40% lower rate of opioid overdose and a 50% lower rate of alcohol intoxication than people with OUD and AUD who do not take Ozempic or similar medications.

Merck pays $700M for clinical-stage CD3xCD19 bispecific antibody

Merck is making its fourth acquisition of the year, this time buying a single asset from a Shanghai-based cancer drug developer. The New Jersey pharma

August 10, 2024

Patients Struggle With Lack of Consistent Coverage for New Weight-Loss Drugs

Supplies of high-demand obesity treatments are improving, but that doesn’t mean it’s easier to get them. Many employers and insurers are scaling back coverage of

February 26, 2025

Morris & Dickson will distribute mpox vaccine Jynneos in the US – Pharmaceutical Technology

Share this article Jynneos was a driver of Bavarian Nordic’s 2023 revenue surge. Credits: Richard H Grant/Shutterstock.com Following Bavarian Nordic’s announcement of the US commercial

April 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.